Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Executive Vice President, Technical Operations
Bellicum Pharmaceuticals
Vice President Regulatory Affairs and Quality Assurance
Gyroscope Therapeutics
Senior Process Scientist
Gyroscope Therapeutics
Head of Cell Culture Media
Boehringer Ingelheim Corporate Center GmbH
Head of Business Development & Partnering
Genethon
Senior Director, EU Section & Public Policy
Alliance for Regeneratice Medicine
Vice President, Global Medical Affairs
Sarepta Therapeutics
Senior Scientist, Oncology Safety Combinations
AstraZeneca
Principal Scientist - Process Sciences
Ichnos Sciences SA
Chief Scientific and Technological Officer
Bone Therapeutics
Vice President Process Development
Evox Therapeutics
President of Research & Cheif Scientific Officer
Orchard Therapeutics
Senior R&D Scientist, Biopharmaceutical Expression Systems Team
Merck KGaA
Scientific leader, Cell & Gene Therapy Platform CMC
GlaxoSmithKline
Vice President, Cell ular Engineering
Kite, A Gilead Company
Chief Medical Officer
Precision BioSciences
Associate Fellow, Investigator Disruptive Technologies
GlaxoSmithKline
Professor of Bioprocess Engineering
University of Sheffield
Director, Global Supply Chain
Kite Pharma
Group Leader: Development Scientist (DSP)
Adaptimmune
Senior Director
Orchard Therapeutics
Professor of Stem Cell Science
King's College London
Executive Director of Regenerative Medicine
Astellas
Chief Scientific Officer
Spark Therapeutics
Associate Professor of Developmental Biology
University of Oxford
Operational Excellence Director - Region Europe
Takeda
Chief Executive Officer
Aivita Biomedical
Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affaird
Novartis
Head of Data & Innovations, Global Commercial Innovation
AstraZeneca
Vice President, Venture Investments
Bayer
Senior Quality Assessor, Biological/Biotechnology Unit
MHRA
Consultant to the ISIA Board of Directors
ISIA
Director, Cell Culture Development
Boehringer Ingelheim Corporate Center GmbH
Assistant Director, Cell Line Development
Genmab
Senior Downstream Process and Technical Transfer Expert Manufacturing Science and Technology
Novartis
Global Head of Cell Banking
AstraZeneca
Senior Director of Gene Therapy manufacturing
Biomarin
Chief Technical Officer
Mustang Bio
Associate Director of Vector Production
Voyager Therapeutics
Senior Scientist, R&D
Celyad
Head of Upstream Process Development
Novartis
Head of Biotherapeutics Development & Drug Supply
Cancer Research UK 
Vice President
Pluristem
Scientific Director & Fellow, Functional Genomics
GlaxoSmithKline
Head of Molecular & Cellular Biology
MRC Harwell
Vice President
Instituto de Biologia Experimental e Tecnologica
Manager, Cell Line Development, Cell and Gene Therapy Product Development
GlaxoSmithKline
Director
Genzyme
Senior Scientist
Spark Therapeutics
Vice President, Process Development
REGENXBIO
Director/Fellow
AstraZeneca
Associate Professor and Group Leader
Inserm
Vice Presdient and Head of Clinical Research & Development
bluebird bio
Scientist, Perfusion / Cell Culture Media
Merck KGaA
Principal Scientist - Gene Therapy
Sanofi
Senior Director, Health Economics & Outcomes Research
uniQure
Senior Vice President, Technical Operations
Sarepta Therapeutics
Director, Senior Global Regulatory Lead, Gene Therapies
CSL Behring
Vice President, R&D Translational Medicine
AveXis, A Novartis Company
Site Head, Cell Therapy Technology Center
Takeda
Associate Professor
UCL
Senior Scientist, Lead of Non-Viral Vector Delivery Project
Kite, A Gilead Company
Group Leader
Kymab
Senior Vice President and Global Head of Research and Early Clinical Development, Cardiovascular, Renal and Metabolic Diseases
AstraZeneca
Associate Principal Scientist
AstraZeneca
Chief Innovation Officer
BlueRock Therapeutics
Group Head CLD1
Novartis
Director
Bristol-Myers Squibb
Professor of Biomedical Engineering
Georgia Institute of Technology
Principal Scientist
Boehringer Ingelheim Corporate Center GmbH
CMC Team Leader
Novartis
Head of CMC
Immunicum
Group Leader Molecular & Cell Line Development
F. Hoffmann-La Roche Ltd
Senior Technical Product Steward for Kymriah
Novartis
Associate Director, Upstream Development
Boehringer Ingelheim Corporate Center GmbH
Professor of Cell Technology
Durham University
Vice President, Head of Biotech Sciences
UCB PHARMA SA
Vice President and Head, Clinical Strategy, Regenerative Medicine
Takeda
Senior Scientist
bluebird bio
Vice President, Product Research & Development
Sanofi
Head of Launch Preparation and Coordination
Bayer AG
Global Head Drug Substance Development, Operational Sciences Mammalian
Novartis
Lead Monoclonal Antibodies Platform, Senior Manager
GlaxoSmithKline
Head of Cell Therapy Development Operations
Juno Therapeutics
Principal Engineer
Bayer AG

Cell Series 2019
Post-Event Report

Statistics, feedback, photos and more from last year's event